Hi
Analyst reports will still be third party opinions based on disclosures by the company and of course their own research. Ultimately it comes down to company disclosures which is what I have raised. It will be very interesting to watch this space as it develops in the compliance gaze.
ta
Update to PD1-Vaxx trial, page-48
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.001(1.75%) |
Mkt cap ! $411.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.5¢ | $390.3K | 7.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 124999 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1243276 | 11 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |